Spain
Althaia, Xarxa Assistencial Universitària de Manresa - Medical Oncology Department
lung cancer, SARS-CoV-2 vaccine, immunity, antibody response, neutralizing IgG antibodies
Lung cancer, NSCLC, Target Mutation, KRAS and molecular profiling